tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Halozyme sees FY24 adjusted EPS $3.55-$3.90, consensus $3.68

Sees FY24 revenue $915M-$985M, consensus $951.47M. Sees FY24 royalty revenue $500M-$525M; and adjusted EBITDA $535M-$585M.

Meet Your ETF AI Analyst

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1